U.S. Markets open in 7 hrs, 27 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 11,632.38 | 29.88 | 0.26% |
| NASDAQ | 2,325.88 | 21.92 | 0.95% |
| S&P 500 | 1,282.19 | 5.19 | 0.41% |
| Day Low 09:41 AM EDT | 19.82 | |
|---|---|---|
| Day High 11:12 AM EDT | 20.25 |
|
| Range | 0.43 | |
| Volume | 335,493 | |
| 30-Day Avg. Vol. | 324,000 |
|
| Difference | 3.55% | |
| Market Cap. | 853.52 M | |
| Change | -3.42 M | |
| Shares Out. | 42.78 M | |
| Percent Traded | 0.78% | |
| Revenue | 134.28 M | |
| Earnings | 29.2 M | |
| EPS (TTM) | 0.70 |
| 52-Wk Low 2/1/08 | 14.33 | |
|---|---|---|
| 52-Wk High 11/30/07 | 25.32 |
|
| Range | 10.99 | |
| Prev. Close 7/22/08 | 20.03 | |
| Today's Open | 19.96 | |
| Change | -0.35% | |
| Dividend (TTM) | 0.00 | |
| Div. Yield (TTM) | 0.00% |
|
| Beta | 1.841 | |
| P/E Ratio (TTM) | 28.10 | |
| P/E Ratio (Fwd.) | 38.00 |
There are many phases in clinical testing, and Phase Forward wants to be one of them. The company provides software that electronically captures data (EDC), manages clinical data (CDM), and automates adverse ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | 0.16 12/31/07 | 0.15 12/31/07 |
-0.01
Missed
|
| Last Quarter | 0.111 3/31/08 | 0.12 3/31/08 |
0.009
Beat
|
| Quarterly - 03/31/2008 | Annual - 2007 | |
|---|---|---|
| Total Revenue | 38.02 M | 134.29 M |
| Gross Profit | 21.84 M | 78.83 M |
| Operating Income | 4.43 M | 13.28 M |
| Net Income | 4.00 M | 29.20 M |
Real-Time Quote
